Medicinal Chemistry

Welcome

Admissions

Curriculum

Seminar Program

Research

Faculty

Staff & PostDocs

Students

Alumni & Friends

Medicinal Chemistry HOME


Faculty

James K. Coward James K. Coward, Ph.D.
Professor of Medicinal Chemistry (College of Pharmacy) and Professor of Chemistry (College of LS&A)
University of Michigan


The University of Michigan
College of Pharmacy
428 Church St.
Ann Arbor, Michigan 48109-1065
Phone: (734) 936-2843
Fax: (734) 647-4865
jkcoward@umich.edu
Coward Lab Website


Education
Ph.D., State University of New York-Buffalo
Bioorganic and Medicinal Chemistry. Organic Chemistry Related to Biological Reactions; Mechanism of Enzyme-Catalyzed Reactions. Synthesis and Enzymology of Mechanism-Based Enzyme Inhibitors


Research
Research in our laboratory involves synthetic and mechanistic organic chemistry employed in combination with mechanistic biochemistry. Three different types of enzymes have been selected for study: folylpolyglutamate synthetase/g-glutamyl hydrolase, glutathionylspermidine synthetase/amidase, and oligosaccharyltransferase.

Folic acid is a key vitamin in human nutrition. Cellular folates contain a reduced pteridine heterocycle and a poly g-glutamyl peptide "tail." Two enzymes, folylpolyglutatmate synthetase (FPGS) and g-glutamyl hydrolase (GH), being studied by our research group, catalyze the biosynthesis and hydrolytic cleavage, respectively, of the polyglutamyl portion of cellular folates and antifolate drugs. Recent research has involved the synthesis of several fluoro- and phosphoamino acids and their incorporation into folates and antifolate drugs. These efforts have led to the synthesis of fluoropeptides or phosphapeptides for biochemical investigation as inhibitors or stimulators of the reactions catalyzed by FPGS or GH. In collaborative research, our new compounds are being used in intact mammalian cells to assess the role of polyglutamate formation and hydrolysis in normal folate-dependent one-carbon biochemistry and also in the pharmacology of antifolate drugs used in the treatment of cancer.

Trypanothione (TSH), found exclusively in trypanosomatid parasites, is a derivative of the ubiquitous antioxidant, glutathione (GSH). The biosynthesis of TSH involves bis-acylation of the polyamine, spermidine, by GSH. The intermediate monoacylated GSH, glutathionylspermidine (Gsp), but not TSH, is found in E. coli and both its synthesis and hyrdrolysis are effected by a unique bifunctional enzyme, Gsp synthetase/amidase. We have extended our phosphapeptide research mentioned above to the development of new inhibitors of TSH biosynthesis as possible anti-trypanosomal drugs. Based on an understanding of the mechanism of Gsp synthetase/amidase, we have designed and synthesized specific phosphapeptide inhibitors of the synthetase domain and, in collaborative research, have used these compounds to study the regulation of catalysis by this bifunctional enzyme.

Oligosaccharyltransferase (OST), an enzyme that catalyzes the N-glycosylation of proteins, is a membrane-bound protein that we isolate from yeast. Initial research has centered on the use of synthetically accessible small substrates, characterization of the chemical structure of the glycopeptide product, and the use of isotopically labeled (1H, 13C, 15N) peptide substrates for mechanistic studies. Recent research has focused on the use of larger peptides and proteins as substrates and has led to extensive studies with invertase-derived peptides of varying length. Kinetic data combined with structure-activity data has allowed us to develop a working hypothesis concerning peptide substrate recognition by OST. Current research also involves the synthesis of a variety of substrate and inhibitors designed to answer specific mechanistic questions. As in the research with the folate polyglutamates and trypanothione, the goal here is to understand the mechanism of this reaction in sufficient detail that it will be feasible to design and synthesize potent and specific inhibitors for use in the study of cellular glycoprotein biosynthesis.


Awards

  • American Cancer Society Scholar in Cancer Research
  • National Institutes of Health Postdoctoral Fellow


Selected Publications

  1. T. Xu, J.K. Coward; "The synthesis and use of 13C and 15N-labeled peptide substrates as mechanistic probes of oligosaccharyltransferase," Biochemistry, 1997, 36, 14683-14689.

  2. C.-H. Lin, S. Chen, D.S. Kwon, J.K. Coward, C.T. Walsh; "Aldehyde and phosphinate analogs of glutathione and glutathionylspermidine: Potent, selective binding inhibitors of the E. coli bifunctional glutathionylspermidine synthetase/amidase," Chem. Biol., 1997, 4, 859-866.

  3. S. Chen, J.K. Coward; "Investigations on new strategies for the facile synthesis of polyfunctionalized phosphinates: Phosphinopeptide analogs of glutathionylspermidine," J. Org. Chem., 1998, 63, 502-509.

  4. A.J. Berdis, I. Lee, J.K. Coward, C. Stephens, R. Wright, L. Shapiro, S.J. Benkovic; "A cell cycle-regulated adenine DNA methyltransferase from Caulobacter crescentus processively methylates GANTC sites on hemimethylated DNA," Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 2874-2879.

  5. T. Tsukamoto, W.H. Haile, J.J. McGuire, J.K. Coward; "Mechanism-based inhibition of human folylpolyglutamate synthetase: Design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate," Arch. Biochem. Biophys., 1998, 355, 109-118.

  6. T. Xu, R.M. Werner, K.-C. Lee, J.C. Fettinger, J.T. Davis, J.K. Coward; "Synthesis and evaluation of tripeptides containing asparagine analogs as potential substrates or inhibitors of oligosaccharyltransferase," J. Org. Chem., 1998, 63, 4767-4778.


Questions/Comments
Rackham School of Graduate Studies | College of Pharmacy
page last modified: Friday, 06-Sep-2002 15:46:38 EDT
©2001 University of Michigan